首页 | 本学科首页   官方微博 | 高级检索  
检索        

鼻咽癌超分割放疗临床研究
引用本文:韦光胜,杨新华,满运艳,孙玉华,孔凡英,郝俊芳,梁超前.鼻咽癌超分割放疗临床研究[J].中华肿瘤防治杂志,1996(3).
作者姓名:韦光胜  杨新华  满运艳  孙玉华  孔凡英  郝俊芳  梁超前
作者单位:山东省肿瘤防治研究院
摘    要:1992年5月至1993年10月将62例鼻咽癌病人随机分为常规放疗组和超分割放疗组。常规放疗组每日1次,1.8~2.0Gy/次,每周五次,总量68~70Gy/34~37次/7~7.4周。超分割放疗组1.1Gy/次,每日2次,间隔≥6~8小时,总量74~77Gy/66~70次/7周。急性粘膜反应超分割放疗组重于常规放疗组(P<0.05),经系统口咽处理病人可以耐受,放疗结束后6个月,临床与CT检查鼻咽肿瘤退缩率两组基本相同。两年生存率和无瘤生存率,常规放疗组分别为83.9%和74.2%。超分割放疗组分别为90.3%和83.9%(P>0.05),近期疗效超分割组略优于常规放疗组,放疗后主要后遗症(张口困难、口干、放射性龋齿等)超分割组明显轻于常规放疗组(P<0.05)。

关 键 词:鼻咽癌  超分割放疗  系统口咽处理

Hyperfractionated irradiation for nasopharyngeal carcinoma(NPC)
Wei guang sheng,Yang xinhua,Man Yunyan,et al..Hyperfractionated irradiation for nasopharyngeal carcinoma(NPC)[J].Chinese Journal of Cancer Prevention and Treatment,1996(3).
Authors:Wei guang sheng  Yang xinhua  Man Yunyan  
Abstract:From May 1992 to October 1993,62 NPC cases were prospectively randomized into two groups:conventional fractionation(CR 68 70Gy/34 37f,7 7.4WK),hyperfractionated irradiation(HFI am1.1 Gy,6 8 hr.later,1.1Gy,to a total dose of 74 77Gy/66 70f,7WK).The acute mucositis of HFI were tolerable by systematic oropharyngeal management.The primary tumor control rates in 6 months were similar between the two groups.The 2 year survival rates and disease free survival rates were 83.9%and 74.2%in CR,whereas 90.3% and 83.9% in HFI.The short term survival of HFI was slightly beter than that of CR (P>0.05).The main sequelae of HFI were more lower than that in CR(P<0.05).
Keywords:Nasopharyngeal Carcinoma  Hyperfractionated lrradiation  Systematic oropharyngeal management  
本文献已被 CNKI 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号